Trokendi XR — Class III drug recall D-0758-2026
Ongoing recall by Supernus Pharmaceuticals, Inc., reported 2026-07-29, distributed nationwide. Failed Dissolution Specifications
| Recall number | D-0758-2026 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Supernus Pharmaceuticals, Inc., Rockville, MD, United States |
| Recall initiated | 2026-07-06 |
| Classified | 2026-08-11 |
| Reported by FDA | 2026-07-29 |
| Distributed | Nationwide (US) |
| Quantity | 15,853 bottles |
| Reason classes | specification failure |
| NDC | 17772-0101-30 |
| Lot numbers | 2075801 |
| Expiration dates | 2029-10-31 |
Product
Trokendi XR, topiramate extended-release capsules, 25mg, 30 Capsules, Rx only, Manufactured by: Catalent Pharma Solutions, Winchester, KY 40391 USA, Manufactured for: Supernus Pharmaceuticals, Inc., Rockville, MD 20850 USA, NDC 17772-101-30.
Reason for recall
Failed Dissolution Specifications
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0758-2026. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.